Teleflex (TFX) Stock Forecast, Price Target & Predictions
TFX Stock Forecast
Teleflex stock forecast is as follows: an average price target of $254.50 (represents a 42.85% upside from TFX’s last price of $178.16) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.
TFX Price Target
TFX Analyst Ratings
Buy
Teleflex Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 31, 2024 | Patrick Wood | Morgan Stanley | $275.00 | $201.06 | 36.78% | 54.36% |
Oct 14, 2024 | Richard Newitter | Truist Financial | $255.00 | $237.10 | 7.55% | 43.13% |
Aug 05, 2024 | Richard Newitter | Truist Financial | $247.00 | $237.13 | 4.16% | 38.64% |
Aug 02, 2024 | Larry Biegelsen | Wells Fargo | $243.00 | $235.95 | 2.99% | 36.39% |
Jul 09, 2024 | Richard Newitter | Truist Financial | $235.00 | $211.73 | 10.99% | 31.90% |
Jul 01, 2024 | Matt O'Brien | Piper Sandler | $245.00 | $210.33 | 16.48% | 37.52% |
May 03, 2024 | Shagun Singh | RBC Capital | $255.00 | $198.73 | 28.31% | 43.13% |
May 02, 2024 | Matthew Taylor | Jefferies | $240.00 | $203.01 | 18.22% | 34.71% |
Jan 06, 2023 | Morgan Stanley | $280.00 | $257.54 | 8.72% | 57.16% | |
Dec 28, 2022 | Stephens | $295.00 | $249.12 | 18.42% | 65.58% | |
Dec 20, 2022 | Truist Financial | $272.00 | $241.63 | 12.57% | 52.67% | |
Apr 29, 2022 | Morgan Stanley | $343.00 | $290.20 | 18.19% | 92.52% | |
Apr 29, 2022 | Raymond James | $355.00 | $289.12 | 22.79% | 99.26% | |
Apr 29, 2022 | Needham | $355.00 | $295.50 | 20.14% | 99.26% | |
Dec 09, 2021 | Alyce Lomax | Motley Fool | $415.00 | $320.03 | 29.68% | 132.94% |
Jul 30, 2021 | Richard Newitter | Leerink Partners | $415.00 | $396.26 | 4.73% | 132.94% |
Teleflex Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 2 | 8 |
Avg Price Target | - | $265.00 | $249.38 |
Last Closing Price | $178.16 | $178.16 | $178.16 |
Upside/Downside | -100.00% | 48.74% | 39.98% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 31, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
Oct 14, 2024 | Truist Financial | Hold | Hold | Hold |
Oct 14, 2024 | Stephens | Underperform | Underperform | Hold |
Oct 08, 2024 | RBC Capital | Outperform | Outperform | Hold |
Aug 02, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Jul 01, 2024 | Piper Sandler | Neutral | Overweight | Upgrade |
May 03, 2024 | Truist Financial | Market Outperform | Market Outperform | Hold |
May 03, 2024 | RBC Capital | Outperform | Outperform | Hold |
May 02, 2024 | Jefferies | Hold | Hold | Hold |
Jan 12, 2024 | Truist Financial | Hold | Hold | Hold |
Dec 20, 2023 | Stephens | Hold | Hold | Hold |
Dec 04, 2023 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
Feb 24, 2023 | CFRA | Buy | Upgrade | |
Jan 06, 2023 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Dec 28, 2022 | Stephens | Overweight | Overweight | Hold |
Aug 22, 2022 | Piper Sandler | Neutral | Neutral | Hold |
Jul 29, 2022 | Wells Fargo | Overweight | Downgrade | |
May 23, 2022 | RBC Capital | Outperform | Outperform | Hold |
Apr 29, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Apr 29, 2022 | Raymond James | Outperform | Outperform | Hold |
Apr 29, 2022 | Needham | Buy | Buy | Hold |
Feb 25, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Feb 23, 2022 | Raymond James | Outperform | Outperform | Hold |
Teleflex Financial Forecast
Teleflex Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $746.39M | $743.26M | $710.93M | $758.00M | $686.79M | $704.54M | $641.72M | $761.91M | $700.25M | $713.47M | $633.92M | $711.18M | $628.30M | $567.03M | $630.64M | $680.95M | $648.32M |
Avg Forecast | $890.79M | $839.65M | $836.44M | $807.53M | $855.50M | $804.39M | $798.44M | $770.30M | $813.14M | $768.68M | $762.98M | $727.54M | $768.72M | $733.56M | $729.87M | $686.83M | $760.35M | $691.53M | $719.52M | $631.89M | $749.61M | $698.20M | $685.80M | $621.03M | $687.67M | $619.33M | $537.91M | $617.73M | $679.01M | $643.20M |
High Forecast | $895.06M | $843.68M | $840.45M | $811.41M | $859.60M | $808.25M | $802.27M | $773.85M | $828.84M | $768.86M | $762.98M | $727.89M | $771.99M | $741.00M | $733.37M | $690.12M | $764.00M | $691.53M | $719.52M | $631.89M | $749.61M | $698.20M | $685.80M | $621.03M | $687.67M | $619.33M | $537.91M | $617.73M | $679.01M | $643.20M |
Low Forecast | $884.93M | $834.13M | $830.94M | $802.23M | $849.88M | $799.10M | $793.19M | $763.99M | $806.55M | $768.50M | $762.98M | $727.19M | $766.07M | $720.70M | $725.08M | $682.32M | $755.35M | $691.53M | $719.52M | $631.89M | $749.61M | $698.20M | $685.80M | $621.03M | $687.67M | $619.33M | $537.91M | $617.73M | $679.01M | $643.20M |
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 8 | 11 | 5 | 7 | 10 | 14 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 6 | 4 | 4 | 7 | 4 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.02% | 1.04% | 1.00% | 0.99% | 0.98% | 1.02% | 1.02% | 1.00% | 1.04% | 1.02% | 1.03% | 1.01% | 1.05% | 1.02% | 1.00% | 1.01% |
Forecast
Teleflex EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 8 | 11 | 5 | 7 | 10 | 14 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 6 | 4 | 4 | 7 | 4 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $137.67M | $111.42M | $177.87M | $146.27M | $183.04M | $192.03M | $164.08M | $214.59M | $299.69M | $176.25M | $163.53M | $152.09M | $189.17M | $96.33M | $213.42M | $173.14M | $170.79M |
Avg Forecast | $238.19M | $224.52M | $223.66M | $215.93M | $228.76M | $215.09M | $213.50M | $205.97M | $217.43M | $205.54M | $204.02M | $214.03M | $205.55M | $196.15M | $195.16M | $194.57M | $231.37M | $186.93M | $194.49M | $153.81M | $202.63M | $188.73M | $185.38M | $133.12M | $185.88M | $167.41M | $145.40M | $179.81M | $183.54M | $173.86M |
High Forecast | $239.33M | $225.59M | $224.73M | $216.97M | $229.85M | $216.12M | $214.52M | $206.92M | $221.63M | $205.59M | $204.02M | $256.84M | $206.42M | $198.14M | $196.10M | $233.49M | $277.64M | $186.93M | $194.49M | $184.58M | $202.63M | $188.73M | $185.38M | $159.74M | $185.88M | $167.41M | $145.40M | $215.78M | $183.54M | $173.86M |
Low Forecast | $236.63M | $223.04M | $222.19M | $214.51M | $227.25M | $213.67M | $212.09M | $204.29M | $215.67M | $205.49M | $204.02M | $171.23M | $204.84M | $192.71M | $193.88M | $155.66M | $185.09M | $186.93M | $194.49M | $123.05M | $202.63M | $188.73M | $185.38M | $106.50M | $185.88M | $167.41M | $145.40M | $143.85M | $183.54M | $173.86M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.70% | 0.57% | 0.91% | 0.63% | 0.98% | 0.99% | 1.07% | 1.06% | 1.59% | 0.95% | 1.23% | 0.82% | 1.13% | 0.66% | 1.19% | 0.94% | 0.98% |
Forecast
Teleflex Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 8 | 11 | 5 | 7 | 10 | 14 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 6 | 4 | 4 | 7 | 4 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $137.14M | $111.33M | $76.75M | $78.59M | $101.89M | $105.51M | $77.14M | $127.46M | $199.18M | $83.25M | $74.87M | $76.13M | $116.59M | $11.46M | $131.15M | $108.27M | $228.93M |
Avg Forecast | $211.92M | $194.43M | $191.14M | $180.96M | $194.74M | $179.94M | $175.43M | $166.09M | $181.57M | $159.48M | $156.62M | $102.27M | $153.46M | $153.70M | $150.79M | $92.97M | $138.09M | $147.50M | $158.27M | $73.49M | $167.26M | $143.34M | $136.00M | $60.94M | $144.38M | $105.99M | $59.44M | $110.50M | $152.30M | $130.07M |
High Forecast | $213.25M | $195.64M | $192.33M | $182.08M | $195.95M | $181.06M | $176.52M | $170.78M | $185.80M | $159.49M | $156.66M | $122.72M | $158.17M | $156.52M | $151.73M | $111.56M | $165.71M | $147.50M | $158.27M | $88.19M | $167.26M | $143.34M | $136.00M | $73.13M | $144.38M | $105.99M | $59.44M | $132.60M | $152.30M | $130.07M |
Low Forecast | $210.11M | $192.77M | $189.51M | $179.41M | $193.07M | $178.40M | $173.93M | $159.05M | $177.33M | $159.47M | $156.59M | $81.81M | $150.64M | $149.47M | $149.50M | $74.38M | $110.47M | $147.50M | $158.27M | $58.80M | $167.26M | $143.34M | $136.00M | $48.76M | $144.38M | $105.99M | $59.44M | $88.40M | $152.30M | $130.07M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.89% | 0.74% | 0.83% | 0.57% | 0.69% | 0.67% | 1.05% | 0.76% | 1.39% | 0.61% | 1.23% | 0.53% | 1.10% | 0.19% | 1.19% | 0.71% | 1.76% |
Forecast
Teleflex SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 8 | 11 | 5 | 7 | 10 | 14 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 6 | 4 | 4 | 7 | 4 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $213.19M | $223.31M | $232.72M | $233.38M | $209.62M | $216.82M | $203.93M | $227.58M | $205.19M | $224.16M | $203.15M | $232.91M | $171.67M | $191.19M | $147.80M | $240.60M | $229.90M |
Avg Forecast | $281.72M | $265.55M | $264.53M | $255.39M | $270.56M | $254.40M | $252.51M | $243.61M | $257.16M | $243.10M | $241.30M | $270.36M | $243.12M | $232.00M | $230.83M | $245.78M | $245.38M | $218.70M | $227.55M | $194.29M | $237.07M | $220.81M | $216.89M | $165.37M | $217.48M | $195.87M | $170.12M | $124.53M | $214.74M | $203.42M |
High Forecast | $283.07M | $266.82M | $265.80M | $256.62M | $271.86M | $255.62M | $253.72M | $244.74M | $262.13M | $243.16M | $241.30M | $324.43M | $244.15M | $234.35M | $231.94M | $294.93M | $294.45M | $218.70M | $227.55M | $233.15M | $237.07M | $220.81M | $216.89M | $198.45M | $217.48M | $195.87M | $170.12M | $149.43M | $214.74M | $203.42M |
Low Forecast | $279.87M | $263.80M | $262.79M | $253.71M | $268.78M | $252.72M | $250.85M | $241.62M | $255.08M | $243.05M | $241.30M | $216.29M | $242.28M | $227.93M | $229.31M | $196.62M | $196.30M | $218.70M | $227.55M | $155.43M | $237.07M | $220.81M | $216.89M | $132.30M | $217.48M | $195.87M | $170.12M | $99.62M | $214.74M | $203.42M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.92% | 0.97% | 0.95% | 0.95% | 0.96% | 0.95% | 1.05% | 0.96% | 0.93% | 1.03% | 1.23% | 1.07% | 0.88% | 1.12% | 1.19% | 1.12% | 1.13% |
Forecast
Teleflex EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 8 | 11 | 5 | 7 | 10 | 14 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 6 | 4 | 4 | 7 | 4 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.92 | $2.37 | $1.63 | $1.68 | $2.17 | $2.25 | $1.65 | $2.72 | $4.26 | $1.78 | $1.60 | $1.63 | $2.51 | $0.25 | $2.83 | $2.34 | $4.95 |
Avg Forecast | $4.51 | $4.14 | $4.07 | $3.85 | $4.14 | $3.83 | $3.73 | $3.53 | $3.86 | $3.39 | $3.33 | $3.08 | $3.26 | $3.27 | $3.21 | $2.97 | $3.44 | $3.11 | $3.34 | $2.72 | $3.53 | $3.03 | $2.87 | $2.42 | $3.05 | $2.24 | $1.25 | $2.33 | $3.22 | $2.75 |
High Forecast | $4.54 | $4.16 | $4.09 | $3.87 | $4.17 | $3.85 | $3.75 | $3.63 | $3.95 | $3.39 | $3.33 | $3.08 | $3.36 | $3.33 | $3.23 | $2.99 | $3.46 | $3.11 | $3.34 | $2.72 | $3.53 | $3.03 | $2.87 | $2.42 | $3.05 | $2.24 | $1.25 | $2.33 | $3.22 | $2.75 |
Low Forecast | $4.47 | $4.10 | $4.03 | $3.82 | $4.11 | $3.79 | $3.70 | $3.38 | $3.77 | $3.39 | $3.33 | $3.07 | $3.20 | $3.18 | $3.18 | $2.94 | $3.41 | $3.11 | $3.34 | $2.72 | $3.53 | $3.03 | $2.87 | $2.42 | $3.05 | $2.24 | $1.25 | $2.33 | $3.22 | $2.75 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.89% | 0.74% | 0.55% | 0.49% | 0.70% | 0.67% | 0.61% | 0.77% | 1.41% | 0.62% | 0.66% | 0.53% | 1.12% | 0.20% | 1.22% | 0.73% | 1.80% |
Forecast
Teleflex Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
TFX | Teleflex | $178.28 | $254.50 | 42.75% | Buy |
ANGO | AngioDynamics | $9.26 | $13.00 | 40.39% | Buy |
HAE | Haemonetics | $82.07 | $107.00 | 30.38% | Buy |
BDX | Becton, Dickinson and Company | $225.64 | $278.75 | 23.54% | Buy |
ATR | AptarGroup | $163.09 | $200.00 | 22.63% | Buy |
COO | Cooper Companies | $94.49 | $115.00 | 21.71% | Buy |
ALC | Alcon | $85.54 | $104.00 | 21.58% | Buy |
ICUI | ICU Medical | $157.17 | $190.50 | 21.21% | Buy |
WST | West Pharmaceutical Services | $334.26 | $393.00 | 17.57% | Buy |
MMSI | Merit Medical Systems | $99.00 | $108.83 | 9.93% | Buy |
NVST | Envista | $19.24 | $20.29 | 5.46% | Hold |
HOLX | Hologic | $72.26 | $74.20 | 2.68% | Buy |
RMD | ResMed | $242.62 | $233.50 | -3.76% | Hold |